Correlation Between Alterola Biotech and Canntab Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Alterola Biotech and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Canntab Therapeutics.

Diversification Opportunities for Alterola Biotech and Canntab Therapeutics

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Alterola and Canntab is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Canntab Therapeutics go up and down completely randomly.

Pair Corralation between Alterola Biotech and Canntab Therapeutics

If you would invest  0.53  in Alterola Biotech on September 1, 2024 and sell it today you would lose (0.03) from holding Alterola Biotech or give up 5.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Alterola Biotech  vs.  Canntab Therapeutics Limited

 Performance 
       Timeline  
Alterola Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Alterola Biotech and Canntab Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alterola Biotech and Canntab Therapeutics

The main advantage of trading using opposite Alterola Biotech and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.
The idea behind Alterola Biotech and Canntab Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals